BMY vs XPL · P/E 17, rev $24.46B vs $76.6M cap
Bristol-Myers Squibb Company (BMY) versus Solitario Exploration & Royalty Corp (XPL) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Solitario Exploration & Royalty Corp (XPL) is a other industrial metals & mining company listed on AMEX.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
XPL does not have a complete income-statement cache yet.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. XPL currently screens at market cap $76.6M.
Not investment advice. Open the BMY and XPL stock pages for the full models.
Not investment advice.